Alector IncNASDAQ:ALEC
- LAST PRICE7.5900
- TODAY'S CHANGE (%)0.2200 (2.9851%)
- Bid / Lots7.1400/ 1
- Ask / Lots7.8000/ 1
- Open / Previous Close7.3400 / 7.3700
- Day Range
- 52 Week Range
- Volume296,119
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ALEC |
|---|---|---|
| 09:32 ET | 3251 | 7.35 |
| 09:34 ET | 350 | 7.335 |
| 09:38 ET | 100 | 7.325 |
| 09:39 ET | 387 | 7.35 |
| 09:41 ET | 100 | 7.48 |
| 09:45 ET | 300 | 7.41 |
| 09:50 ET | 100 | 7.35 |
| 09:52 ET | 100 | 7.35 |
| 10:01 ET | 100 | 7.365 |
| 10:03 ET | 100 | 7.4 |
| 10:08 ET | 200 | 7.4 |
| 10:10 ET | 162 | 7.415 |
| 10:14 ET | 1471 | 7.39 |
| 10:15 ET | 400 | 7.41 |
| 10:17 ET | 200 | 7.42 |
| 10:21 ET | 100 | 7.4 |
| 10:24 ET | 300 | 7.4 |
| 10:26 ET | 200 | 7.41 |
| 10:30 ET | 661 | 7.47 |
| 10:32 ET | 891 | 7.45 |
| 10:33 ET | 100 | 7.43 |
| 10:35 ET | 700 | 7.43 |
| 10:42 ET | 1200 | 7.44 |
| 10:44 ET | 1700 | 7.42 |
| 10:46 ET | 712 | 7.41 |
| 10:53 ET | 300 | 7.41 |
| 10:55 ET | 400 | 7.44 |
| 10:57 ET | 1773 | 7.45 |
| 11:00 ET | 200 | 7.44 |
| 11:02 ET | 105 | 7.45 |
| 11:04 ET | 200 | 7.46 |
| 11:06 ET | 772 | 7.46 |
| 11:08 ET | 200 | 7.46 |
| 11:09 ET | 539 | 7.44 |
| 11:11 ET | 747 | 7.42 |
| 11:13 ET | 700 | 7.4 |
| 11:18 ET | 100 | 7.39 |
| 11:22 ET | 1209 | 7.41 |
| 11:24 ET | 1447 | 7.411 |
| 11:27 ET | 688 | 7.45 |
| 11:29 ET | 300 | 7.435 |
| 11:31 ET | 200 | 7.45 |
| 11:33 ET | 530 | 7.42 |
| 11:38 ET | 300 | 7.41 |
| 11:40 ET | 400 | 7.41 |
| 11:47 ET | 1094 | 7.4 |
| 11:51 ET | 600 | 7.39 |
| 11:54 ET | 221 | 7.385 |
| 11:58 ET | 336 | 7.37 |
| 12:00 ET | 700 | 7.375 |
| 12:02 ET | 200 | 7.38 |
| 12:03 ET | 459 | 7.4 |
| 12:05 ET | 100 | 7.41 |
| 12:07 ET | 524 | 7.45 |
| 12:09 ET | 309 | 7.475 |
| 12:12 ET | 100 | 7.5 |
| 12:14 ET | 200 | 7.475 |
| 12:16 ET | 100 | 7.47 |
| 12:18 ET | 1417 | 7.47 |
| 12:20 ET | 100 | 7.475 |
| 12:21 ET | 938 | 7.5 |
| 12:25 ET | 200 | 7.51 |
| 12:30 ET | 1462 | 7.51 |
| 12:32 ET | 800 | 7.51 |
| 12:36 ET | 222 | 7.51 |
| 12:39 ET | 1002 | 7.52 |
| 12:41 ET | 170 | 7.5083 |
| 12:45 ET | 510 | 7.5 |
| 12:48 ET | 300 | 7.51 |
| 12:50 ET | 320 | 7.495 |
| 12:52 ET | 500 | 7.49 |
| 12:57 ET | 200 | 7.485 |
| 01:01 ET | 100 | 7.49 |
| 01:03 ET | 100 | 7.5 |
| 01:06 ET | 1142 | 7.51 |
| 01:10 ET | 900 | 7.5 |
| 01:12 ET | 296 | 7.52 |
| 01:17 ET | 200 | 7.51 |
| 01:24 ET | 100 | 7.5 |
| 01:26 ET | 639 | 7.5 |
| 01:28 ET | 500 | 7.5 |
| 01:30 ET | 600 | 7.49 |
| 01:32 ET | 700 | 7.495 |
| 01:35 ET | 100 | 7.5 |
| 01:37 ET | 100 | 7.491 |
| 01:39 ET | 200 | 7.49 |
| 01:42 ET | 954 | 7.48 |
| 01:44 ET | 100 | 7.47 |
| 01:46 ET | 800 | 7.48 |
| 01:48 ET | 800 | 7.45 |
| 01:50 ET | 684 | 7.47 |
| 01:51 ET | 100 | 7.47 |
| 01:53 ET | 300 | 7.46 |
| 01:57 ET | 300 | 7.49 |
| 02:00 ET | 620 | 7.48 |
| 02:04 ET | 200 | 7.48 |
| 02:06 ET | 200 | 7.47 |
| 02:08 ET | 300 | 7.455 |
| 02:09 ET | 108 | 7.455 |
| 02:13 ET | 800 | 7.48 |
| 02:15 ET | 200 | 7.48 |
| 02:18 ET | 1319 | 7.47 |
| 02:26 ET | 475 | 7.49 |
| 02:27 ET | 200 | 7.495 |
| 02:31 ET | 100 | 7.49 |
| 02:33 ET | 759 | 7.5 |
| 02:36 ET | 894 | 7.51 |
| 02:38 ET | 959 | 7.485 |
| 02:42 ET | 300 | 7.485 |
| 02:44 ET | 733 | 7.49 |
| 02:45 ET | 200 | 7.4867 |
| 02:51 ET | 100 | 7.49 |
| 02:54 ET | 800 | 7.49 |
| 02:56 ET | 400 | 7.51 |
| 03:02 ET | 400 | 7.52 |
| 03:03 ET | 997 | 7.53 |
| 03:05 ET | 960 | 7.52 |
| 03:09 ET | 200 | 7.515 |
| 03:14 ET | 1199 | 7.51 |
| 03:16 ET | 462 | 7.52 |
| 03:18 ET | 706 | 7.52 |
| 03:20 ET | 100 | 7.51 |
| 03:21 ET | 100 | 7.505 |
| 03:25 ET | 508 | 7.5 |
| 03:27 ET | 800 | 7.5 |
| 03:30 ET | 1493 | 7.49 |
| 03:32 ET | 960 | 7.505 |
| 03:34 ET | 1700 | 7.53 |
| 03:36 ET | 300 | 7.52 |
| 03:38 ET | 200 | 7.515 |
| 03:39 ET | 1100 | 7.51 |
| 03:41 ET | 800 | 7.55 |
| 03:43 ET | 1400 | 7.55 |
| 03:45 ET | 3118 | 7.555 |
| 03:48 ET | 1574 | 7.57 |
| 03:50 ET | 1300 | 7.58 |
| 03:52 ET | 2100 | 7.565 |
| 03:54 ET | 4541 | 7.58 |
| 03:56 ET | 5207 | 7.6 |
| 03:57 ET | 7361 | 7.61 |
| 03:59 ET | 9267 | 7.59 |
May 5, 2023
--Barclays Adjusts Price Target on Alector to $12 From $14, Maintains Overweight Rating, from 10:13AM ET on Friday May 05, 2023 by MT Newswires
10:13AM ET on Friday May 05, 2023 by MT Newswires
May 4, 2023
Alector Reports First Quarter 2023 Financial Results and Provides Business Update, from 4:05PM ET on Thursday May 04, 2023 by GlobeNewswire
4:05PM ET on Thursday May 04, 2023 by GlobeNewswire
May 2, 2023
Alector to Participate in the BofA Securities 2023 Healthcare Conference, from 7:00AM ET on Tuesday May 02, 2023 by GlobeNewswire
7:00AM ET on Tuesday May 02, 2023 by GlobeNewswire
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Alector Inc | 632.6M | -4.8x | --- |
2Seventy Bio Inc | 601.4M | -2.2x | --- |
Repare Therapeutics Inc | 433.5M | -13.1x | --- |
Somalogic Inc | 554.4M | -3.9x | --- |
Regenxbio Inc | 791.1M | -2.9x | --- |
Agenus Inc | 505.9M | -1.8x | --- |
Company Information
Alector, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on immuno-neurology, a therapeutic approach for the treatment of neurodegenerative diseases. The Company is engaged in developing therapies designed to counteract these pathologies by restoring healthy immune function to the brain. Its research and drug discovery platform leverages human genetic datasets, advanced tools in bioinformatics and imaging, and insights in neurodegeneration and immunology to identify immune system. Its clinical programs include AL001 (latozinemab), AL101, and AL002. In addition, the Company also focuses on preclinical and research programs in its pipeline for indications, including Alzheimer’s disease, Parkinson’s disease, and oncology. Its first product candidate, latozinemab, is a humanized recombinant monoclonal antibody that increases the levels of progranulin (PGRN) in the brains of frontotemporal dementia carrying a progranulin (FTD-GRN) patients.
Contact Information
- Headquarters
- 131 OYSTER POINT BLVD., SUITE 600SOUTH SAN FRANCISCO, CA, United States 94080
- Phone
- 415-231-5660
- Fax
- 302-655-5049
Executives
- Co-Founder, Director
- Tillman Gerngross
- President, Head - Research and Development
- Saraswati Kenkare-mitra
- Chief Executive Officer, Co-Founder, Director
- Arnon Rosenthal
- Chief Financial Officer
- Marc Grasso
- Chief Medical Officer
- Gary Romano
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $632.6M |
|---|---|
Revenue (TTM) | $125.7M |
Shares Outstanding | 83.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.77 |
EPS | $-1.58 |
Book Value | $2.59 |
P/E Ratio | -4.8x |
Price/Sales (TTM) | 5.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -114.43% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
